Profile Image

Staff Profile

Edit

Career Summary

Biography

Dr Talseth-Palmer was awarded her PhD in January 2008, which was undertaken in the HMRI's NBN Telethon Childhood Cancer research laboratory. She was awarded the research higher degree award for excellence in the Faculty of Health in recognition of outstanding research achievement for her Doctor of Philosophy research thesis. In January 2008, she successfully obtained a Gladys M. Brawn Memorial Post-Doctoral fellowship from the University of Newcastle and is now a part of the HMRI's, Information-Based Medicine Research Program.

Prior to completing her PhD, Dr Talseth-Palmer completed a Bachelor of Medical Laboratory Technology in Norway in 1999 and a Masters of Genetic Counselling at the University of Newcastle in 2004. Between 1999 and 2003, Dr Talseth-Palmer worked as a research assistant focusing on genetic research both in Iceland and Norway.

In 2006, Dr Talseth-Palmer was awarded a travel grant to attend the 11th International Congress of Human Genetics by the Human Genetics Society of Australasia (HGSA). In 2008, she was nominated as 10 of the best research showcases at the University of Newcastle and, in 2009, she was awarded the Hunter Medical Research Institute (HMRI) Pulse Education Prize, an award presented to outstanding early career researchers. Dr Talseth-Palmer is also an invited reviewer for the journal, Cancer Causes & Control.

Qualifications

  • Doctor of Philosophy, University of Newcastle, 18/12/2007
  • Master of Genetic Counselling, University of Newcastle, 16/09/2004

Research

Research keywords

  • Acute Lymphoblastic Leukaemia (ALL)
  • Genetic variation
  • Genome-wideSNP array technology
  • Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
  • Modifier genes
  • Single Nucleotide Polymorphisms (SNPs)

Research expertise

  • Single Nucleotide Polymorphisms (SNPs)
  • Modifier genes
  • Genetic variation
  • Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
  • Acute Lymphoblastic Leukaemia (ALL)
  • Genome-wideSNP array technology

Languages

  • English
  • Norwegian

Fields of Research

CodeDescriptionPercentage
060400Genetics50
111200Oncology And Carcinogenesis40
111700Public Health And Health Services10

Memberships

Body relevant to professional practice.

  • Member - Human Genetics Society of Australasia (HGSA)
  • Member - Australian Society for Medical Research (ASMR)

Other

  • Member - Business & Professional Woman (BPW) Australia
  • Member - Hunter Childrens Research Executive (HCRE) Subcommittee
  • Member - The Australasian Microarray & Associated Technologies Association (AMATA)

Appointments

Glady's M. Brawn Memorial Post-Doctoral Fellow
University of Newcastle (Australia)
01/01/2008 - 01/12/2010
NHMRC Training (Post-Doctoral) Fellow
University of Newcastle (Australia)
01/01/2011

Awards

Other

2008Higher degree excellence
University of Newcastle (Australia)
Award for research higher degree excellence in the Faculty of Health in recognition of outstanding research achievement for the Doctor of Philosophy Research thesis
2004NBN Telethon Childhood Cancer PhD Scholarship
University of Newcastle (Australia)
$20000 per annum for 3 years

Research Award.

2009Hunter Medical Research Institute (HMRI) Pulse Education Prize
Hunter Medical Research Insitute (Australia)
Support to attend the International Society for Gastrointestinal Hereditary Tumours meeting June 2009, Dusseldorf, Germany
2008Poster prize
HMRI Conference on Translational Cancer Research (Australia)
Best student poster
2006Travel grant
Human Genetics Society of Australasia (HGSA) (Australia)
support to attend the 11th International Congress of Human Genetics, Brisbane, August 2006
2005Cancer Institute NSW Research Scholar Award
Cancer Institute NSW (Australia)
$25000 per annum for 3 years

Collaboration

Dr Talseth-Palmer is currently collaborating in several international studies: HNPCC, Juul Wijnen, LUMC, the Netherlands; MOMA study, Malcolm Dunlop, MRC, UK; 6-SNP collaboration, Annika Lindblom, Karolinska Institute, Sweden; and Modifier genes in HNPCC, Jan Lubinski, International Hereditary Cancer Center, Poland.

Teaching

Teaching keywords

  • Honours supervision
Edit

Highlighted Publications

For publications that are currently unpublished or in-press, details are shown in italics.

YearCitationAltmetricsLink
2009Talseth-Palmer B, Bowden NA, Meldrum C, Nicholl J, Thompson E, Friend K, et al., 'A 1q44 deletion, paternal UPD of chromosome 2 and a deletion due to a complex translocation detected in children with abnormal phenotypes using new SNP array technology', Cytogenetic and Genome Research, 124 94-101 (2009) [C1]
2008Talseth-Palmer B, Ashton KA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott R, 'Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer', International Journal of Cancer, 122 1273-1277 (2008) [C1]
2008Talseth-Palmer B, McPhillips M, Meldrum C, Groombridge C, Spigelman A, Scott R, 'Hereditary nonpolyposis colorectal cancer in families: Mutations, age of diagnosis of cancer and cancer incidence', Conference on Translational Cancer Research: Abstracts, Newcastle, NSW (2008) [E3]

Co-authors: Rodney Scott

2007Talseth-Palmer B, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott R, 'MDM2 SNP309 T > G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients', International Journal of Cancer, 120 563-565 (2007) [C1]
2006Talseth-Palmer B, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott R, 'Age of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53', International Journal of Cancer, 118 2479-2484 (2006) [C1]
2003Louka AS, Lie BA, Talseth B, Ascher H, Ek J, Gudjonsdottir AH, Sollid LM, 'Coeliac disease patients carry conserved HLA-DR3-DQ2 haplotypes revealed by association of TNF alleles', Immunogenetics, 55 339-343 (2003) [C1]
2001Kristinsson S, Thorolfsdottir E, Talseth B, Steingrimsson E, Thorsson A, Helgason T, et al., 'MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1. (2001) [C1]

Publications

For publications that are currently unpublished or in-press, details are shown in italics.

Click on a category title below to expand the list of citations for that specific category.

Chapter (1 outputs)

YearCitationAltmetricsLink
2012Scott R, Reeves SG, Talseth-Palmer B, 'The role of modifier genes in Lynch Syndrome', Colorectal Cancer Biology From Genes To Tumor, InTech, Slovenia 37-58 (2012) [B1]

Co-authors: Rodney Scott

Journal article (28 outputs)

YearCitationAltmetricsLink
2014Masson AL, Talseth-Palmer BA, Evans TJ, Grice DM, Hannan GN, Scott RJ, 'Expanding the genetic basis of copy number variation in familial breast cancer.', Hered Cancer Clin Pract, 12 15 (2014)
2013Talseth-Palmer B, Holliday EG, Evans T-J, McEvoy MA, Attia JR, Grice DM, et al., 'Continuing difficulties in interpreting CNV data: Lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients', BMC Medical Genomics, 6 1-13 (2013) [C1]
2013Picelli S, Lorenzo Bermejo J, Chang-Claude J, Hoffmeister M, Fernandez-Rozadilla C, Carracedo A, et al., 'Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility', PLOS ONE, 8 (2013) [C1]
2013Talseth-Palmer BA, Wijnen JT, Grice DM, Scott RJ, 'Genetic modifiers of cancer risk in Lynch syndrome: a review', FAMILIAL CANCER, 12 207-216 (2013) [C1]
2013Talseth-Palmer BA, Wijnen JT, Andreassen EK, Barker D, Jagmohan-Changur S, Tops CM, et al., 'The importance of a large sample cohort for studies on modifier genes influencing disease severity in FAP patients.', Hered Cancer Clin Pract, 11 20 (2013) [C1]
2013Chen J, Pande M, Huang Y-J, Wei C, Amos CI, Talseth-Palmer BA, et al., 'Cell cycle-related genes as modifiers of age of onset of colorectal cancer in Lynch syndrome: a large-scale study in non-Hispanic white patients', CARCINOGENESIS, 34 299-306 (2013) [C1]
2013Masson AL, Talseth-Palmer BA, Evans T-J, Grice DM, Duesing K, Hannan GN, Scott RJ, 'Copy number variation in hereditary non-polyposis colorectal cancer', Genes, 4 536-555 (2013) [C1]
2013Talseth-Palmer B, Wijnen JT, Brenne IS, Jagmohan-Changur S, Barker DJ, Ashton KA, et al., 'Combined analysis of three Lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers', International Journal of Cancer, 132 1487-1729 (2013) [C1]
2013Talseth-Palmer BA, Wijnen JT, Barker D, Vasen HFA, Scott RJ, 'Is the reported modifying effect of 8q23.3 and 11q23.1 on colorectal cancer risk for MLH1 mutation carriers valid? Reply', INTERNATIONAL JOURNAL OF CANCER, 133 1764-1764 (2013) [C3]
2012Talseth-Palmer B, Scott R, Vasen HFA, Wijnen JT, '8q23.3 and 11q23.1 as modifying loci influencing the risk for CRC in Lynch syndrome', European Journal of Human Genetics, 20 487-488 (2012) [C3]

Co-authors: Rodney Scott

2011Wong-Brown M, Nordfors C, Mossman D, Pecenpetelovska G, Kiejda KA, Talseth-Palmer B, et al., 'BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer', Breast Cancer Research and Treatment, 127 853-859 (2011) [C1]
2011Talseth-Palmer B, Scott R, 'Genetic variation and its role in malignancy', International Journal of Biomedical Science, 7 158-171 (2011) [C1]

Co-authors: Rodney Scott

2011Kiejda KA, Bowden NA, Croft AJ, Scurr LL, Kairupan CF, Ashton KA, et al., 'P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation', BMC Cancer, 11 203-219 (2011) [C1]
2011Talseth-Palmer B, Brenne IS, Ashton KA, Evans T-J, McPhillips M, Groombridge C, et al., 'Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in lynch syndrome', Journal of Medical Genetics, 48 279-284 (2011) [C1]
2010Talseth-Palmer B, McPhillips M, Groombridge C, Spigelman A, Scott R, 'MSH6 and PMS2 mutation positive Australian Lynch syndrome families: Novel mutations, cancer risk and age of diagnosis of colorectal cancer', Hereditary Cancer in Clinical Practice, 8 1-10 (2010) [C1]
2009Shi Z, Johnstone DM, Talseth-Palmer B, Evans T-J, Spigelman AD, Groombridge C, et al., 'Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age', International Journal of Cancer, 125 78-83 (2009) [C1]
2009Talseth-Palmer B, Bowden NA, Meldrum C, Nicholl J, Thompson E, Friend K, et al., 'A 1q44 deletion, paternal UPD of chromosome 2 and a deletion due to a complex translocation detected in children with abnormal phenotypes using new SNP array technology', Cytogenetic and Genome Research, 124 94-101 (2009) [C1]
2008Talseth-Palmer B, Ashton KA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott R, 'Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer', International Journal of Cancer, 122 1273-1277 (2008) [C1]
2008Talseth-Palmer B, Bowden NA, Hill A, Meldrum C, Scott R, 'Whole genome amplification and its impact on CGH array profiles', BMC Research Notes, 1 108 (2008) [C1]
2007Talseth-Palmer B, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott R, 'Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer', Scandinavian Journal of Gastroenterology, 42 628-632 (2007) [C1]
2007Talseth-Palmer B, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott R, 'MDM2 SNP309 T > G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients', International Journal of Cancer, 120 563-565 (2007) [C1]
2006Talseth-Palmer B, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott R, 'Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients', Cancer Epidemiology Biomarkers & Prevention, 15 2307-2310 (2006) [C1]
2006Talseth-Palmer B, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott R, 'Age of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53', International Journal of Cancer, 118 2479-2484 (2006) [C1]
2003Louka AS, Lie BA, Talseth B, Ascher H, Ek J, Gudjonsdottir AH, Sollid LM, 'Coeliac disease patients carry conserved HLA-DR3-DQ2 haplotypes revealed by association of TNF alleles', Immunogenetics, 55 339-343 (2003) [C1]
2003Babron M-C, Nilsson S, Adamovic S, Naluai ÅT, Wahlström J, Ascher H, et al., 'Meta and pooled analysis of European coeliac disease data', European Journal of Human Genetics, 11 828-834 (2003)
2003Louka AS, Moodie SJ, Karell K, Bolognesi E, Ascher H, Greco L, et al., 'A collaborative European search for non-DQA1 *05-DQB1 *02 Celiac disease loci on HLA-Dr3 haplotypes: Analysis of transmission from homozygous parents', Human Immunology, 64 350-358 (2003)
2002Louka A, Nilsson S, Olsson M, Talseth B, Lie B, Ek J, et al., 'HLA in coeliac disease families: a novel test of risk modification by the 'other' haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. (2002) [C1]
2001Kristinsson S, Thorolfsdottir E, Talseth B, Steingrimsson E, Thorsson A, Helgason T, et al., 'MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1. (2001) [C1]
Show 25 more

Conference (20 outputs)

YearCitationAltmetricsLink
2013Talseth-Palmer B, Meldrum C, Ashton KA, Spigelman A, Scott RJ, 'Revealing cancer complexity - Identification of Lynch syndrome cases', Familial Cancer, Carins, QLD (2013) [E3]
2013Talseth-Palmer B, Wijnen JT, Andreassen EK, Jagmohan-Changur S, Barker D, Tops CM, et al., 'The importance of a large sample cohort for studies on modifier genes influencing disease development in FAP patients', Familial Cancer, Carins, QLD (2013) [E3]

Co-authors: Rodney Scott

2012Talseth-Palmer B, Holliday EG, Evans T-J, McEvoy MA, Attia JR, Grice DM, et al., 'A genome-wide CNV association study of Australian HNPCC/Lynch syndrome patients', Proceedings of the Australian Health & Medical Research Congress 2012, Adelaide, SA (2012) [E3]
2012Talseth-Palmer B, Wijen J, Brenne I, Jagomohan-Changur S, Baker D, Ashton KA, et al., 'Colorectal cancer risk modification in Lynch syndrome', Human Genome Meeting 2012: Genetics and Genomics in Personalised Medicine. Abstract Book, Sydney, NSW (2012) [E3]
2012Talseth-Palmer B, Scott R, 'A step closer to personalised medicine for Lynch Syndrome patients - Personalised screening can prevent cancer development in MLH1 mutation carriers', BDC 2012. 2nd Biomarker Discovery Conference, Shoal Bay, NSW (2012) [E3]

Co-authors: Rodney Scott

2011Talseth-Palmer B, Wijnen JT, Brenne IS, Jagmohan-Changur S, Ashton KA, Tops CM, et al., 'Chromosome 8q23.3 AND 11q23.1 variants modify colorectal cancer risk in Lynch syndrome: A meta-analysis of the Dutch and Australian Lynch syndrome cohorts', Abstracts: 4th Biennial Meeting: International Society for Gastrointestinal Hereditary Tumours, San Antonio, TX (2011) [E3]
2011Martin AL, Talseth-Palmer B, Grice DM, Hannan G, Scott R, 'Elucidating the genetic predisposition to colorectal cancer', XIX NSW Scientific Meeting. Programme, Sydney, NSW (2011) [E3]

Co-authors: Rodney Scott

2011Talseth-Palmer B, Wijnen JT, Brenne IS, Jagmohan-Changur S, Ashton KA, Tops CM, et al., 'Chromosome 8q23.3, 10p14 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome - a combined analysis of the Australian, Dutch and Polish Lynch syndrome cohorts', Familial Aspects of Cancer: Research and Practice 2011, Kingscliff, NSW (2011) [E3]
2010Scott R, Talseth-Palmer B, Reeves SG, Meldrum, Groombridge C, Spigelman AD, et al., 'MTHFR 677 C>T and 1298 A>C polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer', Familial Cancer, Dusseldorf, Germany (2010) [E3]
2010Talseth-Palmer B, Holliday EG, Evans T-J, McPhillips M, McEvoy MA, Attia JR, Scott R, 'A modern approach to the search for modifying genetic loci infleuncing the high breast cancer incidence seen in an Australian HNPCC/Lynch Syndrome cohort', Proceedings of the Australian Health and Medical Research Congress 2010, Melbourne, Vic (2010) [E3]
2010Talseth-Palmer BA, Brenne IS, Ashton K, Evans TJ, McPhillips M, Groombridge C, et al., 'Colorectal cancer susceptibility loci on chr 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome', EJC SUPPLEMENTS, Oslo, NORWAY (2010) [E3]
2010Talseth-Palmer B, Holliday EG, Evans T-J, McPhillips M, Groombridge C, Spigelman AD, Scott R, 'Modifier genes influencing breast cancer incidence in HNPCC/Lynch syndrome', AMATA 2010 Conference: Conference Handbook, Hobart, Tasmania (2010) [E3]
2010Talseth-Palmer B, McPhillips M, Meldrum C, Groombridge C, Spigelman AD, Scott R, 'Hereditary nonpolyposis colorectal cancer in 688 families: Mutations, age of diagnosis and cancer incidence', Familial Cancer, Dusseldorf, Germany (2010) [E3]

Co-authors: Rodney Scott

2010Talseth-Palmer B, McPhillips M, Meldrum C, Groombridge C, Spigelman AD, Scott R, 'Haemochromatosis HFE gene polymorphisms as ptential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age', Familial Cancer, Dusseldorf, Germany (2010) [E3]

Co-authors: Rodney Scott

2010Evans T-J, Talseth-Palmer B, Brenne IS, Ashton KA, McPhillips M, Groombridge C, et al., 'Colorectal cancer suspectibility loci on chr 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome', Sydney Cancer Conference 2010. Profiling Risk, Personalising Treatment and Predicting Outcomes. Conference Program and Abstract Book, Sydney, NSW (2010) [E3]
2009Evans T-J, Bowden NA, Talseth-Palmer B, Catchpoole D, Scott R, 'Copy number variation in childhood acute lmphoblastic leukaemia', AMATA 2009, Katoomba, NSW (2009) [E3]
2008Talseth-Palmer B, McPhillips M, Meldrum C, Groombridge C, Spigelman A, Scott R, 'Hereditary nonpolyposis colorectal cancer in families: Mutations, age of diagnosis of cancer and cancer incidence', Conference on Translational Cancer Research: Abstracts, Newcastle, NSW (2008) [E3]

Co-authors: Rodney Scott

2005Talseth-Palmer B, Meldrum C, Ashton KA, Scott R, 'Age of disease onset in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53', Human Genetics Society of Australasia 29th Annual Conference, Newcastle, NSW (2005) [E3]
2005Ashton KA, Talseth-Palmer B, Meldrum CJ, McPhillips ML, Scott R, 'COMT polymorphism (V158M) and its association with endometrial cancer in HNPCC families that adhere to the Amsterdam or Bethesda criteria', Human Genetics Society of Australasia 29th Annual Conference, Newcastle, NSW (2005) [E3]
2003Naluai AT, Adamovic S, Louka AS, Nilsson S, Talseth B, Gudjonsdottir AH, et al., 'Celiac disease is associated to a haplotype on 5q in Scandinavian families.', AMERICAN JOURNAL OF HUMAN GENETICS, LOS ANGELES, CALIFORNIA (2003)
Show 17 more
Edit

Grants and Funding

Summary

Number of grants10
Total funding$1,194,038

- Indicates that the researcher may be seeking students for this project.

Click on a grant title below to expand the full details for that specific grant.

2014 (1 grants)

Identification of genetic factors of inherited colon cancer$599,798
Funding Body: Cancer Institute NSW

Project Team
Doctor Bente Talseth-Palmer
SchemeRole
Early Career FellowshipChief Investigator
Total AmountFunding StartFunding Finish
$599,79820142018
GNo:G1200857

2013 (1 grants)

Uncovering the link between obesity and cancer using random forests in an elastic cloud$57,208
Funding Body: Cancer Institute NSW

Project Team
Professor Rodney Scott, Doctor Bente Talseth-Palmer
SchemeRole
NSW Premier's Awards for Outstanding Cancer Research: "Big Data, Big Impact" GrantInvestigator
Total AmountFunding StartFunding Finish
$57,20820132015
GNo:G1300824

2012 (1 grants)

Revealing cancer complexity - identification of Lynch syndrome cases$10,000
Funding Body: University of Newcastle

Project Team
Doctor Bente Talseth-Palmer, Professor Rodney Scott, Doctor Liz Holliday
SchemeRole
Early Career Researcher GrantChief Investigator
Total AmountFunding StartFunding Finish
$10,00020122012
GNo:G1200519

2011 (1 grants)

Genetics of HNPCC$290,032
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Doctor Bente Talseth-Palmer
SchemeRole
Training (Postdoctoral) Fellowships - Peter Doherty Biomedical Fellowship (Australia)Chief Investigator
Total AmountFunding StartFunding Finish
$290,03220112014
GNo:G1000522

2010 (1 grants)

The 21st Meeting of the European Association for Cancer Research, Norges Varemesse (Norway Trade Fairs), 26 - 29 June 2010$2,000
Funding Body: University of Newcastle - Faculty of Health and Medicine

Project Team
Doctor Bente Talseth-Palmer
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$2,00020102010
GNo:G1000515

2009 (3 grants)

Genome wide SNP associated study of childhood acute lymphoblastic leukaemia$140,000
Funding Body: Hunter Medical Research Institute

Project Team
Professor Rodney Scott, Doctor Nikola Bowden, Doctor Bente Talseth-Palmer
SchemeRole
Paediatric Oncology Project GrantInvestigator
Total AmountFunding StartFunding Finish
$140,00020092010
GNo:G0189790

Search for modifier genes influencing breast cancer incidence in families diagnosed with hereditary nonpolyposis colorectal cancer$60,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Bente Talseth-Palmer, Professor Rodney Scott
SchemeRole
Breast Cancer Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$60,00020092009
GNo:G0189856

PULSE Education Prize$4,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Bente Talseth-Palmer
SchemeRole
PULSE Education PrizeChief Investigator
Total AmountFunding StartFunding Finish
$4,00020092009
GNo:G0189891

2008 (1 grants)

Genome wide SNP association study of childhood acute lymphoblastic leukaemia$20,000
Funding Body: Hunter Children`s Research Foundation

Project Team
Doctor Nikola Bowden, Professor Rodney Scott, Doctor Bente Talseth-Palmer
SchemeRole
Paediatric Oncology Project GrantInvestigator
Total AmountFunding StartFunding Finish
$20,00020082008
GNo:G0188483

2006 (1 grants)

Genetic origins of childhood cancer$11,000
Funding Body: Hunter Medical Research Institute

Project Team
Professor Rodney Scott, Doctor Bente Talseth-Palmer
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$11,00020062006
GNo:G0186093
Edit

Research Supervision

Number of current supervisions1
Total current UoN PhD EFTSL0.2

For supervisions undertaken at an institution other that the University of Newcastle, the institution name is listed below the program name.

Current Supervision

CommencedProposed
Completion
ProgramSupervisor TypeResearch Title
20112015PhD (Medical Genetics)Co-SupervisorElucidating the Genetic Predisposition to Colorectal Cancer
Edit

Dr Bente Talseth-Palmer

Work Phone(02) 4042 0328
Email
PositionCancer Institute ECR Fellow
Medical Genetics/Centre for Information-Based Medicine
School of Biomedical Sciences and Pharmacy
Faculty of Health and Medicine
The University of Newcastle, Australia
Focus AreaMedical Genetics
Office
Room 3105, Level 3 West, HMRI,
HMRI,
Rankin Park
URL:www.newcastle.edu.au/profile/bente-talseth-palmer